Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer

NCT02139358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gemcitabine
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]